-
1
-
-
39049170984
-
Global strategy for asthma management and prevention: GINA executive summary
-
Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-78.
-
(2008)
Eur Respir J
, vol.31
, pp. 143-178
-
-
Bateman, E.D.1
Hurd, S.S.2
Barnes, P.J.3
-
2
-
-
0035938606
-
Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: A randomized controlled trial
-
Lazarus SC. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 2001; 20: 2583-93.
-
(2001)
JAMA
, vol.20
, pp. 2583-2593
-
-
Lazarus, S.C.1
-
3
-
-
1842370350
-
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establisning Therapy (FACET) International Study Group
-
Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establisning Therapy (FACET) International Study Group. N Engl J Med 1997; 337: 1405-11.
-
(1997)
N Engl J Med
, vol.337
, pp. 1405-1411
-
-
Pauwels, R.A.1
Lofdahl, C.G.2
Postma, D.S.3
-
4
-
-
33644873375
-
Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma
-
Ni CM, Greenstone I, Danish A, et al. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database Syst Rev 2005; CD005535.
-
(2005)
Cochrane Database Syst Rev
-
-
Ni, C.M.1
Greenstone, I.2
Danish, A.3
-
5
-
-
5144221336
-
Can guidelinedefined asthma control be achieved? The gaining optimal asthma control study
-
Bateman ED, Boushey HA, Bousquet J, et al. Can guidelinedefined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004; 170: 836-44.
-
(2004)
Am J Respir Crit Care Med
, vol.170
, pp. 836-844
-
-
Bateman, E.D.1
Boushey, H.A.2
Bousquet, J.3
-
6
-
-
0035119165
-
Long-acting beta-agonist tratment in patients with persistent asthma already receiving inhaled corticosteroids
-
Hancox RJ, Taylor DR. Long-acting beta-agonist tratment in patients with persistent asthma already receiving inhaled corticosteroids. Bio Drugs 2001; 15: 11-24.
-
(2001)
Bio Drugs
, vol.15
, pp. 11-24
-
-
Hancox, R.J.1
Taylor, D.R.2
-
7
-
-
84987766532
-
-
Global Initiative for Asthma Web site [Internet]. USA: Global Strategy for Asthma Management and Prevention. Available from
-
The Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma Web site [Internet]. USA: Global Strategy for Asthma Management and Prevention. Available from www.ginasthma.org, 2008.
-
(2008)
-
-
-
8
-
-
26244468792
-
Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial
-
Haney S, Hancox RJ. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial. Respir Res 2005; 6: 107.
-
(2005)
Respir Res
, vol.6
, pp. 107
-
-
Haney, S.1
Hancox, R.J.2
-
9
-
-
0032724502
-
Development and validation of a questionnaire to measure asthma control
-
Juniper EF, O'Byrne, PM, Guyatt, GH, Ferrie, PJ, King, DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-7.
-
(1999)
Eur Respir J
, vol.14
, pp. 902-907
-
-
Juniper, E.F.1
O'Byrne, P.M.2
Guyatt, G.H.3
Ferrie, P.J.4
King, D.R.5
-
10
-
-
16344381781
-
Rapid onset of tolerance to beta-agonist bronchodilation
-
Haney S, Hancox RJ. Rapid onset of tolerance to beta-agonist bronchodilation. Respir Med 2005; 99: 566-71.
-
(2005)
Respir Med
, vol.99
, pp. 566-571
-
-
Haney, S.1
Hancox, R.J.2
|